The Patent Finder

Antipodean Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Antipodean Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 4 of 4 · Back to Antipodean Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 7,888,335Mitoquinone derivatives used as mitochondrially targeted antioxidants
Term ended
Term ended Jun 27, 2026 · From the USPTO record
Term endedTerm ended Jun 27, 2026From the USPTO record
US 7,179,928Synthesis of triphenylphosphonium quinols and quinones
Term ended
Term ended Jan 9, 2023 · From the USPTO record
Term endedTerm ended Jan 9, 2023From the USPTO record
US 6,331,532Mitochondrially targeted antioxidants
Term ended
Term ended May 25, 2020 · From the USPTO record
Term endedTerm ended May 25, 2020From the USPTO record
US 7,232,809Mitochondrially targeted antioxidants
Lapsed on the fee record
Ended Jun 19, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jun 19, 2019From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited